Development of an anti-microbial peptide-mediated liposomal delivery system: a novel approach towards pH-responsive anti-microbial peptides

References

• Almaaytah A, Zhou M, Wang L, et al. (2012). Antimicrobial/cytolytic peptides from the venom of the north african scorpion, androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog. Peptides 35:291–9
   PubMed Web of Science ®Google Scholar
• Attoub S, Mechkarska M, Sonnevend A, et al. (2013). Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells. Peptides 39:95–102
   PubMed Web of Science ®Google Scholar
• Bandekar A, Zhu C, Gomez A, et al. (2013). Masking and triggered unmasking of targeting ligands on liposomal chemotherapy selectively suppress tumor growth in vivo. Mol Pharm 10:152–60
   PubMed Web of Science ®Google Scholar
• Brown KL, Hancock RE. (2006). Cationic host defense (antimicrobial) peptides. Curr Opin Immunol 18:24–30
   PubMed Web of Science ®Google Scholar
• Chen L, Tu Z, Voloshchuk N, et al. (2012). Lytic peptides with improved stability and selectivity designed for cancer treatment. J Pharm Sci 101:1508–17
   PubMed Web of Science ®Google Scholar
• Di Francesco A, Favaroni A, Donati M. (2013). Host defense peptides: general overview and an update on their activity against chlamydia spp. Expert Rev Anti-Infect Therapy 11:1215–24
   PubMed Web of Science ®Google Scholar
• Dreaden EC, El-Sayed MA. (2012). Emerging nanomaterials for targeting subcellular organelles. Acc Chem Res 45:1854–65
   PubMed Web of Science ®Google Scholar
• Fjell CD, Hiss JA, Hancock RE, Schneider G. (2011). Designing antimicrobial peptides: form follows function. Nature Rev Drug Discov 11:37–51
   PubMed Web of Science ®Google Scholar
• Guaní-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, et al. (2010). Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol 135:1–11
   PubMed Web of Science ®Google Scholar
• Hancock RE, Sahl HG. (2006). Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nature Biotechnol 24:1551–7
   PubMed Web of Science ®Google Scholar
• Helmlinger G, Yuan F, Dellian M, et al. (1997). Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nature Med 3:177–82
   PubMed Web of Science ®Google Scholar
• Henriques ST, Melo MN, Castanho MA. (2006). Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem J 399:1–7
   PubMed Web of Science ®Google Scholar
• Hou KK, Pan H, Lanza GM, Wickline SA. (2013). Melittin derived peptides for nanoparticle based siRNA transfection. Biomaterials 34:3110–19
   PubMed Web of Science ®Google Scholar
• Huang C, Jin H, Qian Y, et al. (2013). Hybrid melittin cytolytic peptide-driven ultrasmall lipid nanoparticles block melanoma growth in vivo. ACS Nano 7:5791–5800
   PubMed Web of Science ®Google Scholar
• Jiang T, Zhang Z, Zhang Y, et al. (2012). Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. Biomaterials 33:9246–58
   PubMed Web of Science ®Google Scholar
• Kazemzadeh-Narbat M, Kindrachuk J, Duan K, et al. (2010). Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections. Biomaterials 31:9519–26
   PubMed Web of Science ®Google Scholar
• Kazemzadeh-Narbat M, Lai BF, Ding C, et al. (2013). Multilayered coating on titanium for controlled release of antimicrobial peptides for the prevention of implant-associated infections. Biomaterials 34:5969–77
   PubMed Web of Science ®Google Scholar
• Mangoni ML. (2011). Host-defense peptides: from biology to therapeutic strategies. Cell Mol Life Sci 68:2157–9
   PubMed Web of Science ®Google Scholar
• Manzoor AA, Lindner LH, Landon CD, et al. (2012). Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. Cancer Res 72:5566–75
   PubMed Web of Science ®Google Scholar
• Makovitzki A, Fink A, Shai Y. (2009). Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides. Cancer Res 69:3458–63
   PubMed Web of Science ®Google Scholar
• Nguyen LT, Haney EF, Vogel HJ. (2011). The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol 29:464–72
   PubMed Web of Science ®Google Scholar
• Papo N, Seger D, Makovitzki A, et al. (2006). Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide. Cancer Res 66:5371–8
   PubMed Web of Science ®Google Scholar
• Papo N, Shai Y. (2005). Host defense peptides as new weapons in cancer treatment. Cell Mol Life Sci 62:784–90
   PubMed Web of Science ®Google Scholar
• Perry JL, Reuter KG, Kai MP, et al. (2012). PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett 12:5304–10
   PubMed Web of Science ®Google Scholar
• Reddy KV, Yedery RD, Aranha C. (2004). Antimicrobial peptides: premises and promises. Int J Antimicrobial Agents 24:536–47
   PubMed Web of Science ®Google Scholar
• Riedl S, Zweytick D, Lohner K. (2011). Membrane-active host defense peptides – challenges and perspectives for the development of novel anticancer drugs. Chem Phys Lipids 164:766–81
   PubMed Web of Science ®Google Scholar
• Salomone F, Cardarelli F, Di Luca M, et al. (2012). A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape. J Control Release 163:293–303
   PubMed Web of Science ®Google Scholar
• Santo KP, Irudayam SJ, Berkowitz ML. (2013). Melittin creates transient pores in a lipid bilayer: results from computer simulations. J Phys Chem B 117:5031–42
   PubMed Web of Science ®Google Scholar
• Splith K, Neundorf I. (2011). Antimicrobial peptides with cell-penetrating peptide properties and vice versa. Eur Biophys J 40:387–97
   PubMed Web of Science ®Google Scholar
• Tan YX, Chen C, Wang YL, et al. (2012). Truncated peptides from melittin and its analog with high lytic activity at endosomal pH enhance branched polyethylenimine-mediated gene transfection. J Gene Med 14:241–50
   PubMed Web of Science ®Google Scholar
• Tannock IF, Rotin D. (1989). Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 49:4373–84
   PubMed Web of Science ®Google Scholar
• Tian L, Bae YH. (2012). Cancer nanomedicines targeting tumor extracellular pH. Colloids Surf B Biointerfaces 99:116–26
   PubMed Web of Science ®Google Scholar
• Tu Z, Volk M, Shah K, et al. (2009). Constructing bioactive peptides with pH-dependent activities. Peptides 30:1523–8
   PubMed Web of Science ®Google Scholar
• Urbán P, Valle-Delgado JJ, Moles E, et al. (2012). Nanotools for the delivery of antimicrobial peptides. Cur Drug Targets 13:1158–72
   PubMed Web of Science ®Google Scholar
• Veldhoen S, Laufer SD, Trampe A, et al. (2006). Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect. Nucleic Acids Res 4:6561–73
   Web of Science ®Google Scholar
• Xiang S, Tong H, Shi Q, et al. (2012). Uptake mechanisms of non-viral gene delivery. J Control Release 158:371–8
   PubMed Web of Science ®Google Scholar
• Xu S, Olenyuk BZ, Okamoto CT, et al. (2013). Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances. Adv Drug Deliv Rev 65:121–38
   PubMed Web of Science ®Google Scholar
• Yang K, Wan J, Zhang S, et al. (2011). In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. ACS Nano 5:516–22
   PubMed Web of Science ®Google Scholar
• Yeung AT, Gellatly SL, Hancock RE. (2011). Multifunctional cationic host defense peptides and their clinical applications. Cell Mol Life Sci 68:2161–76
   PubMed Web of Science ®Google Scholar
• Zasloff M. (2002). Antimicrobial peptides of multicellular organisms. Nature 415:389–95
   PubMed Web of Science ®Google Scholar
• Zhang W, Song J, Zhang B, et al. (2011). Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells. Bioconjugate Chem 22:1410–15
   PubMed Web of Science ®Google Scholar
• Zhang Y, Satterlee A, Huang L. (2012). In vivo gene delivery by nonviral vectors: overcoming hurdles &quest. Mol Therapy 20:1298–304
   PubMed Web of Science ®Google Scholar
• Zhao BX, Zhao Y, Huang Y, et al. (2012). The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel. Biomaterials 33:2508–20
   PubMed Web of Science ®Google Scholar